Austrian Left Atrial Appendage Closure Registry

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2025 → Dec 2027
See other at-risk trials from Medical University of Graz

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2025 to Dec 2027
    • Eligibility criteria expanded, about 2 words
  2. Primary and study completion dates: May 2024 to Dec 2025v8
  3. Primary and study completion dates: May 2023 to May 2024v7
  4. Primary and study completion dates: May 2022 to May 2023v6
  5. Primary and study completion dates: May 2021 to May 2022v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: May 2020 to May 2021v4
  2. Primary and study completion dates: Dec 2019 to May 2020v3
  3. Primary and study completion dates: Dec 2018 to Dec 2019v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.
Trial Details
NCT Number NCT03409159
Lead Sponsor Medical University of Graz
Conditions
(from sponsor)		 Atrial Fibrillation, Left Atrial Appendage Closure
Related terms Atrial Fibrillation
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov